PHARMACEUTICAL FORMULATIONS FOR MINIMIZING DRUG-DRUG INTERACTIONS
    1.
    发明申请
    PHARMACEUTICAL FORMULATIONS FOR MINIMIZING DRUG-DRUG INTERACTIONS 审中-公开
    用于最小化药物相互作用的药物制剂

    公开(公告)号:US20060280786A1

    公开(公告)日:2006-12-14

    申请号:US11423491

    申请日:2006-06-12

    IPC分类号: A61K9/127 A61K9/14

    摘要: A pharmaceutical combination for minimizing pharmacokinetic drug-drug interaction is described including a first pharmaceutical component having a particular pharmacokinetic profile in a mammal and a second pharmaceutical component formulated for parenteral administration having an altered pharmacokinetic profile different from the unaltered pharmacokinetic profile of the second pharmaceutical component, which would interfere with the pharmacokinetic profile of the first pharmaceutical component. Due to its altered pharmacokinetic profile, the second pharmaceutical component does not substantially affect the pharmacokinetic profile of the first pharmaceutical component.

    摘要翻译: 描述了用于最小化药代动力学药物 - 药物相互作用的药物组合物,其包括在哺乳动物中具有特定药代动力学特征的第一药物组分和用于非肠道给药的第二药物组分,所述第二药物组分具有不同于第二药物组分的未改变的药代动力学特征的药代动力学特征 ,其将干扰第一药物组分的药代动力学特征。 由于其药代动力学变化的改变,第二药物组分基本上不影响第一药物组分的药代动力学特征。

    Bimetallic-cyanide catalysts used for preparing polyether polyols
    5.
    发明授权
    Bimetallic-cyanide catalysts used for preparing polyether polyols 失效
    用于制备聚醚多元醇的双金属氰化物催化剂

    公开(公告)号:US06878661B1

    公开(公告)日:2005-04-12

    申请号:US09744357

    申请日:1999-07-20

    IPC分类号: C08G65/10 C08G65/26 B01J31/00

    摘要: The invention relates to novel double metal cyanide (DMC) catalysts for the preparation of polyether polyols by polyaddition of alkylene oxides to starter compounds containing active hydrogen atoms, wherein the catalyst contains a) double metal cyanide compounds, b) organic complex ligands other than c), and c) complex ligands formed by introduction of a glycidyl ether into the catalyst. The catalysts according to the invention have greatly increased activity in the preparation of polyether polyols.

    摘要翻译: 本发明涉及用于制备聚醚多元醇的新型双金属氰化物(DMC)催化剂,其通过将环氧烷加成到含有活性氢原子的起始化合物中,其中催化剂含有a)双金属氰化物化合物,b)除c以外的有机络合物配体 ),和c)通过将缩水甘油醚引入催化剂而形成的复合配位体。 根据本发明的催化剂在制备聚醚多元醇中的活性大大增加。

    Crystalline double metal cyanide catalysts for producing polyether polyols
    9.
    发明授权
    Crystalline double metal cyanide catalysts for producing polyether polyols 有权
    用于生产聚醚多元醇的结晶双金属氰化物催化剂

    公开(公告)号:US06323375B1

    公开(公告)日:2001-11-27

    申请号:US09509979

    申请日:2000-04-05

    IPC分类号: C07C4311

    CPC分类号: C08G65/2663 B01J27/26

    摘要: The present invention relates to highly active, substantially crystalline double metal cyanide (DMC) catalysts, a process for the preparation of these double metal cyanide catalysts, a process for producing polyether polyols by the polyaddition of alcohol ethers onto starter compounds containing active hydrogen atoms from these DMC catalysts, and to the polyether polyols produced by this process. The DMC catalysts of the invention comprise a) double metal cyanide compounds, b) organic complexing ligands, and c) functionalized polymers. These catalysts exhibit increased activity in the process for the production of polyether polyols.

    摘要翻译: 本发明涉及高活性,基本上结晶的双金属氰化物(DMC)催化剂,制备这些双金属氰化物催化剂的方法,通过将醇醚加成到含有活性氢原子的起始化合物上制备聚醚多元醇的方法 这些DMC催化剂,以及通过该方法制备的聚醚多元醇。 本发明的DMC催化剂包括a)双金属氰化物化合物,b)有机络合配体,和c)官能化聚合物。 这些催化剂在制备聚醚多元醇的方法中表现出增加的活性。